Company profile DYN

Dyne Therapeutics Inc
Description of the company is not available.
Quarter analysis & expected interestLast update: February 08 2024 20:49:56.

After 39 days of this quarter the interest is at 79.0. Based on that we can calculate that during remaining 52 days it will total up to 184.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
201916
38
137.5% QoQ
80
110.5% QoQ
63
-21.2% QoQ
2020 77
381.2% YoY 22.2% QoQ
96
152.6% YoY 24.7% QoQ
158
97.5% YoY 64.6% QoQ
44
-30.2% YoY -72.2% QoQ
2021 213
176.6% YoY 384.1% QoQ
164
70.8% YoY -23.0% QoQ
103
-34.8% YoY -37.2% QoQ
73
65.9% YoY -29.1% QoQ
2022 122
-42.7% YoY 67.1% QoQ
127
-22.6% YoY 4.1% QoQ
132
28.2% YoY 3.9% QoQ
104
42.5% YoY -21.2% QoQ
2023 202
65.6% YoY 94.2% QoQ
88
-30.7% YoY -56.4% QoQ
169
28.0% YoY 92.0% QoQ
180
73.1% YoY 6.5% QoQ
2024 79
-60.9% YoY -56.1% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Dyne Therapeutics search interestLast update: February 08 2024 20:49:55.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 20:49:57.

The average 5 years interest of Dyne Therapeutics was 8.92 per week.
The last year interest of Dyne Therapeutics compared to the last 5 years has changed by 37.11%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 169.38%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 07 2024 07:35:10.

After 38 days of this quarter the interest is at 148.0. Based on that we can calculate that during remaining 53 days it will total up to 354.0.
Force platform expected interest is significantly lower compared to previous quarter (-44.4%) and same quarter last year (-47.5%).

YearQ1Q2Q3Q4
2019345
493
42.9% QoQ
535
8.5% QoQ
678
26.7% QoQ
2020 588
70.4% YoY -13.3% QoQ
628
27.4% YoY 6.8% QoQ
668
24.9% YoY 6.4% QoQ
820
20.9% YoY 22.8% QoQ
2021 678
15.3% YoY -17.3% QoQ
603
-4.0% YoY -11.1% QoQ
635
-4.9% YoY 5.3% QoQ
793
-3.3% YoY 24.9% QoQ
2022 738
8.8% YoY -6.9% QoQ
650
7.8% YoY -11.9% QoQ
657
3.5% YoY 1.1% QoQ
796
0.4% YoY 21.2% QoQ
2023 674
-8.7% YoY -15.3% QoQ
609
-6.3% YoY -9.6% QoQ
525
-20.1% YoY -13.8% QoQ
637
-20.0% YoY 21.3% QoQ
2024 148
-78.0% YoY -76.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Force platform search interestLast update: February 07 2024 07:35:10.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 07 2024 07:35:10.

The average 5 years interest of Force platform was 49.61 per week.
The last year interest of Force platform compared to the last 5 years has changed by -8.95%.
The interest for Force platform is seasonal.
The last year interest is comparable to 5 years ago. It has changed only by 3.74%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 20:50:14.

After 39 days of this quarter the interest is at 5.0. Based on that we can calculate that during remaining 52 days it will total up to 12.0.
Myotonic dystrophy expected interest is significantly lower compared to previous quarter (-45.5%) and same quarter last year (-45.5%).

YearQ1Q2Q3Q4
201914
19
35.7% QoQ
18
-5.3% QoQ
20
11.1% QoQ
2020 19
35.7% YoY -5.0% QoQ
13
-31.6% YoY -31.6% QoQ
13
-27.8% YoY 0.0% QoQ
14
-30.0% YoY 7.7% QoQ
2021 15
-21.1% YoY 7.1% QoQ
13
0.0% YoY -13.3% QoQ
16
23.1% YoY 23.1% QoQ
13
-7.1% YoY -18.8% QoQ
2022 21
40.0% YoY 61.5% QoQ
131
907.7% YoY 523.8% QoQ
21
31.2% YoY -84.0% QoQ
20
53.8% YoY -4.8% QoQ
2023 22
4.8% YoY 10.0% QoQ
19
-85.5% YoY -13.6% QoQ
22
4.8% YoY 15.8% QoQ
22
10.0% YoY 0.0% QoQ
2024 5
-77.3% YoY -77.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Myotonic dystrophy search interestLast update: February 08 2024 20:50:14.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 20:50:15.

The average 5 years interest of Myotonic dystrophy was 1.8 per week.
The last year interest of Myotonic dystrophy compared to the last 5 years has changed by -15.56%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by 1.33%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 20:50:20.

After 39 days of this quarter the interest is at 353.0. Based on that we can calculate that during remaining 52 days it will total up to 824.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019677
744
9.9% QoQ
650
-12.6% QoQ
843
29.7% QoQ
2020 905
33.7% YoY 7.4% QoQ
671
-9.8% YoY -25.9% QoQ
601
-7.5% YoY -10.4% QoQ
608
-27.9% YoY 1.2% QoQ
2021 650
-28.2% YoY 6.9% QoQ
524
-21.9% YoY -19.4% QoQ
531
-11.6% YoY 1.3% QoQ
657
8.1% YoY 23.7% QoQ
2022 812
24.9% YoY 23.6% QoQ
778
48.5% YoY -4.2% QoQ
704
32.6% YoY -9.5% QoQ
847
28.9% YoY 20.3% QoQ
2023 937
15.4% YoY 10.6% QoQ
847
8.9% YoY -9.6% QoQ
698
-0.9% YoY -17.6% QoQ
925
9.2% YoY 32.5% QoQ
2024 353
-62.3% YoY -61.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Duchenne muscular dystrophy search interestLast update: February 08 2024 20:50:20.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 20:50:24.

The average 5 years interest of Duchenne muscular dystrophy was 57.33 per week.
The last year interest of Duchenne muscular dystrophy compared to the last 5 years has changed by 11.93%.
The interest for Duchenne muscular dystrophy is seasonal.
The last year interest is comparable to 5 years ago. It has changed only by 0.72%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 20:50:29.

After 39 days of this quarter the interest is at 23.0. Based on that we can calculate that during remaining 52 days it will total up to 54.0.
Facioscapulohumeral dystrophy expected interest is significantly lower compared to previous quarter (-87.3%) and same quarter last year (-72.6%).

YearQ1Q2Q3Q4
2019210
187
-11.0% QoQ
260
39.0% QoQ
276
6.2% QoQ
2020 372
77.1% YoY 34.8% QoQ
94
-49.7% YoY -74.7% QoQ
274
5.4% YoY 191.5% QoQ
170
-38.4% YoY -38.0% QoQ
2021 319
-14.2% YoY 87.6% QoQ
266
183.0% YoY -16.6% QoQ
382
39.4% YoY 43.6% QoQ
263
54.7% YoY -31.2% QoQ
2022 348
9.1% YoY 32.3% QoQ
267
0.4% YoY -23.3% QoQ
148
-61.3% YoY -44.6% QoQ
269
2.3% YoY 81.8% QoQ
2023 197
-43.4% YoY -26.8% QoQ
265
-0.7% YoY 34.5% QoQ
254
71.6% YoY -4.2% QoQ
424
57.6% YoY 66.9% QoQ
2024 23
-88.3% YoY -94.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Facioscapulohumeral dystrophy search interestLast update: February 08 2024 20:50:29.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 20:50:30.

The average 5 years interest of Facioscapulohumeral dystrophy was 20.18 per week.
The last year interest of Facioscapulohumeral dystrophy compared to the last 5 years has changed by 5.0%.
The interest for Facioscapulohumeral dystrophy is seasonal.
The last year interest is comparable to 5 years ago. It has changed only by -0.56%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Rare skeletal muscle diseases to provide analysis

Correlation between past revenue and Rare skeletal muscle diseases search interest

There is not enough data for Rare skeletal muscle diseases to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Rare skeletal muscle diseases to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Cardiac and metabolic muscle diseases to provide analysis

Correlation between past revenue and Cardiac and metabolic muscle diseases search interest

There is not enough data for Cardiac and metabolic muscle diseases to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Cardiac and metabolic muscle diseases to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Dyne Therapeutics jobs to provide analysis

Correlation between past revenue and Dyne Therapeutics jobs search interest

There is not enough data for Dyne Therapeutics jobs to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Dyne Therapeutics jobs to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Dyne Therapeutics reviews to provide analysis

Correlation between past revenue and Dyne Therapeutics reviews search interest

There is not enough data for Dyne Therapeutics reviews to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Dyne Therapeutics reviews to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Dyne Therapeutics Massachusetts to provide analysis

Correlation between past revenue and Dyne Therapeutics Massachusetts search interest

There is not enough data for Dyne Therapeutics Massachusetts to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Dyne Therapeutics Massachusetts to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for DYN
Earnings date: 2024-02-29 After close
Company name: Dyne Therapeutics Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-13T18:38:04Z

Analyst Upgrades
Bernstein Maintains Market Perform on Dyne Therapeutics, Raises Price Target to $24

2026-05-13T11:30:00Z

GlobeNewswire
Dyne Therapeutics to Participate in Upcoming Investor Conferences

2026-05-11T11:30:00Z

GlobeNewswire
Dyne Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights

2026-04-27T20:34:05Z

GlobeNewswire
Dyne Therapeutics Announces Upcoming Presentation Highlighting Robust CNS Activity in Nonhuman Primates with its FORCEā„¢ Platform at 2026 ASGCT Annual Meeting

2026-04-23T20:05:00Z

GlobeNewswire
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2026-04-01T11:30:00Z

GlobeNewswire
Dyne Therapeutics Announces Participation at 2026 Academy of Managed Care Pharmacy (AMCP) Conference to Begin Shaping Access in US for Potential Neuromuscular Medicines

2026-03-09T18:13:25Z

Analyst Upgrades
Chardan Capital Maintains Buy on Dyne Therapeutics, Maintains $38 Price Target

2026-03-08T22:01:00Z

GlobeNewswire
Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1)

2026-03-08T22:00:00Z

GlobeNewswire
Dyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)

2026-03-06T16:33:37+0000

CNBC
FDA reversals leave investors worrying about the fates of other experimental drugs

2026-03-03T16:45:33Z

Analyst Upgrades
Morgan Stanley Maintains Overweight on Dyne Therapeutics, Lowers Price Target to $47

2026-03-03T12:01:47Z

Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Dyne Therapeutics, Lowers Price Target to $50

2026-03-02T12:30:00Z

GlobeNewswire
Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

2026-02-26T10:52:43Z

Analyst Upgrades
Sarepta CEO To Jump Ship After 'Tumultuous' Year

2026-02-25T12:30:00Z

GlobeNewswire
Dyne Therapeutics to Participate in Upcoming Investor Conferences